nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—hematologic cancer	0.102	0.596	CbGaD
Fludrocortisone—NR3C1—hematologic cancer	0.0694	0.404	CbGaD
Fludrocortisone—Dexamethasone—hematologic cancer	0.0681	0.208	CrCtD
Fludrocortisone—Betamethasone—hematologic cancer	0.0681	0.208	CrCtD
Fludrocortisone—Triamcinolone—hematologic cancer	0.0665	0.203	CrCtD
Fludrocortisone—Prednisone—hematologic cancer	0.0631	0.193	CrCtD
Fludrocortisone—Prednisolone—hematologic cancer	0.0616	0.188	CrCtD
Fludrocortisone—NR3C2—Betamethasone—hematologic cancer	0.0406	0.243	CbGbCtD
Fludrocortisone—NR3C2—Prednisolone—hematologic cancer	0.04	0.24	CbGbCtD
Fludrocortisone—NR3C2—Dexamethasone—hematologic cancer	0.0236	0.142	CbGbCtD
Fludrocortisone—NR3C1—Triamcinolone—hematologic cancer	0.0156	0.0936	CbGbCtD
Fludrocortisone—NR3C1—Betamethasone—hematologic cancer	0.0134	0.0803	CbGbCtD
Fludrocortisone—NR3C1—Prednisolone—hematologic cancer	0.0132	0.0793	CbGbCtD
Fludrocortisone—NR3C1—Prednisone—hematologic cancer	0.0125	0.0748	CbGbCtD
Fludrocortisone—NR3C1—Dexamethasone—hematologic cancer	0.00778	0.0467	CbGbCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—hematologic cancer	0.0036	0.0166	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisolone—hematologic cancer	0.00352	0.0162	CrCrCtD
Fludrocortisone—Flurandrenolide—Dexamethasone—hematologic cancer	0.00305	0.0141	CrCrCtD
Fludrocortisone—Flurandrenolide—Betamethasone—hematologic cancer	0.00305	0.0141	CrCrCtD
Fludrocortisone—Flurandrenolide—Prednisolone—hematologic cancer	0.00276	0.0128	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—hematologic cancer	0.00265	0.0122	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisolone—hematologic cancer	0.00258	0.0119	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—hematologic cancer	0.00256	0.0118	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00253	0.0117	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00253	0.0117	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisolone—hematologic cancer	0.0025	0.0116	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00248	0.0114	CrCrCtD
Fludrocortisone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00247	0.0114	CrCrCtD
Fludrocortisone—Amcinonide—Betamethasone—hematologic cancer	0.00247	0.0114	CrCrCtD
Fludrocortisone—Amcinonide—Dexamethasone—hematologic cancer	0.00247	0.0114	CrCrCtD
Fludrocortisone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00247	0.0114	CrCrCtD
Fludrocortisone—Amcinonide—Triamcinolone—hematologic cancer	0.00241	0.0111	CrCrCtD
Fludrocortisone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00241	0.0111	CrCrCtD
Fludrocortisone—Diflorasone—Betamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Desonide—Dexamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Prednisone—Betamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Diflorasone—Dexamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Prednisone—Dexamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Desonide—Betamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Clobetasol propionate—Betamethasone—hematologic cancer	0.0024	0.0111	CrCrCtD
Fludrocortisone—Prednisone—Triamcinolone—hematologic cancer	0.00235	0.0108	CrCrCtD
Fludrocortisone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00235	0.0108	CrCrCtD
Fludrocortisone—Desonide—Triamcinolone—hematologic cancer	0.00235	0.0108	CrCrCtD
Fludrocortisone—Diflorasone—Triamcinolone—hematologic cancer	0.00235	0.0108	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00229	0.0106	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—hematologic cancer	0.00229	0.0106	CrCrCtD
Fludrocortisone—Desoximetasone—Betamethasone—hematologic cancer	0.00229	0.0106	CrCrCtD
Fludrocortisone—Desoximetasone—Dexamethasone—hematologic cancer	0.00229	0.0106	CrCrCtD
Fludrocortisone—Desoximetasone—Triamcinolone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Amcinonide—Prednisolone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Fluoxymesterone—Prednisolone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Fluorometholone—Betamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Mometasone—Betamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Triamcinolone—Betamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Mometasone—Dexamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Triamcinolone—Dexamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Fluorometholone—Dexamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Loteprednol—Betamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Loteprednol—Dexamethasone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Desonide—Prednisone—hematologic cancer	0.00223	0.0103	CrCrCtD
Fludrocortisone—Dexamethasone—Betamethasone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Betamethasone—Dexamethasone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Fluorometholone—Triamcinolone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Mometasone—Triamcinolone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Loteprednol—Triamcinolone—hematologic cancer	0.00218	0.0101	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Prednisone—Prednisolone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Progesterone—Prednisolone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Diflorasone—Prednisolone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Desonide—Prednisolone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—hematologic cancer	0.00217	0.01	CrCrCtD
Fludrocortisone—Betamethasone—Triamcinolone—hematologic cancer	0.00213	0.00984	CrCrCtD
Fludrocortisone—Dexamethasone—Triamcinolone—hematologic cancer	0.00213	0.00984	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisolone—hematologic cancer	0.00212	0.0098	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—hematologic cancer	0.00212	0.00979	CrCrCtD
Fludrocortisone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00209	0.00964	CrCrCtD
Fludrocortisone—Methylprednisolone—Betamethasone—hematologic cancer	0.00209	0.00964	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisolone—hematologic cancer	0.00207	0.00956	CrCrCtD
Fludrocortisone—Prednisolone—Betamethasone—hematologic cancer	0.00204	0.00943	CrCrCtD
Fludrocortisone—Prednisolone—Dexamethasone—hematologic cancer	0.00204	0.00943	CrCrCtD
Fludrocortisone—Methylprednisolone—Triamcinolone—hematologic cancer	0.00204	0.00942	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—hematologic cancer	0.00202	0.00934	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—hematologic cancer	0.00202	0.00934	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisolone—hematologic cancer	0.00202	0.00933	CrCrCtD
Fludrocortisone—Mometasone—Prednisolone—hematologic cancer	0.00202	0.00933	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00202	0.00933	CrCrCtD
Fludrocortisone—Loteprednol—Prednisolone—hematologic cancer	0.00202	0.00933	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisolone—hematologic cancer	0.00202	0.00933	CrCrCtD
Fludrocortisone—Prednisolone—Triamcinolone—hematologic cancer	0.00199	0.00922	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisolone—hematologic cancer	0.00197	0.00912	CrCrCtD
Fludrocortisone—Betamethasone—Prednisolone—hematologic cancer	0.00197	0.00912	CrCrCtD
Fludrocortisone—Hydrocortisone—Betamethasone—hematologic cancer	0.00196	0.00905	CrCrCtD
Fludrocortisone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00196	0.00905	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—hematologic cancer	0.00193	0.00894	CrCrCtD
Fludrocortisone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00191	0.00885	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—hematologic cancer	0.00189	0.00875	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisolone—hematologic cancer	0.00189	0.00872	CrCrCtD
Fludrocortisone—Testosterone—Prednisolone—hematologic cancer	0.00189	0.00872	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—hematologic cancer	0.00182	0.00839	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisolone—hematologic cancer	0.00177	0.00819	CrCrCtD
Fludrocortisone—NR3C2—hematopoietic system—hematologic cancer	0.000464	0.117	CbGeAlD
Fludrocortisone—AR—hematopoietic system—hematologic cancer	0.000344	0.0864	CbGeAlD
Fludrocortisone—NR3C2—blood—hematologic cancer	0.000307	0.0773	CbGeAlD
Fludrocortisone—NR3C2—lung—hematologic cancer	0.000269	0.0677	CbGeAlD
Fludrocortisone—AR—gonad—hematologic cancer	0.000261	0.0657	CbGeAlD
Fludrocortisone—NR3C2—testis—hematologic cancer	0.000254	0.0639	CbGeAlD
Fludrocortisone—NR3C1—hematopoietic system—hematologic cancer	0.000249	0.0625	CbGeAlD
Fludrocortisone—AR—blood—hematologic cancer	0.000228	0.0572	CbGeAlD
Fludrocortisone—AR—lung—hematologic cancer	0.0002	0.0502	CbGeAlD
Fludrocortisone—NR3C1—gonad—hematologic cancer	0.000189	0.0476	CbGeAlD
Fludrocortisone—AR—testis—hematologic cancer	0.000188	0.0473	CbGeAlD
Fludrocortisone—NR3C2—lymph node—hematologic cancer	0.000184	0.0463	CbGeAlD
Fludrocortisone—NR3C1—blood—hematologic cancer	0.000165	0.0414	CbGeAlD
Fludrocortisone—NR3C1—bone marrow—hematologic cancer	0.00016	0.0401	CbGeAlD
Fludrocortisone—NR3C1—lung—hematologic cancer	0.000145	0.0363	CbGeAlD
Fludrocortisone—AR—lymph node—hematologic cancer	0.000136	0.0343	CbGeAlD
Fludrocortisone—NR3C1—testis—hematologic cancer	0.000136	0.0343	CbGeAlD
Fludrocortisone—NR3C1—lymph node—hematologic cancer	9.88e-05	0.0248	CbGeAlD
Fludrocortisone—Testosterone Propionate—UGT1A1—hematologic cancer	7.01e-05	0.0442	CrCbGaD
Fludrocortisone—Desonide—NR3C1—hematologic cancer	5.92e-05	0.0373	CrCbGaD
Fludrocortisone—Diflorasone—NR3C1—hematologic cancer	5.92e-05	0.0373	CrCbGaD
Fludrocortisone—Desoximetasone—NR3C1—hematologic cancer	5.77e-05	0.0364	CrCbGaD
Fludrocortisone—Loteprednol—NR3C1—hematologic cancer	5.7e-05	0.036	CrCbGaD
Fludrocortisone—Flurandrenolide—NR3C1—hematologic cancer	5.05e-05	0.0319	CrCbGaD
Fludrocortisone—Testosterone Propionate—AR—hematologic cancer	5.01e-05	0.0316	CrCbGaD
Fludrocortisone—Hydrocortamate—NR3C1—hematologic cancer	4.89e-05	0.0308	CrCbGaD
Fludrocortisone—Cortisone acetate—NR3C1—hematologic cancer	4.81e-05	0.0303	CrCbGaD
Fludrocortisone—Fluoxymesterone—AR—hematologic cancer	4.64e-05	0.0293	CrCbGaD
Fludrocortisone—Megestrol acetate—NR3C1—hematologic cancer	4.64e-05	0.0292	CrCbGaD
Fludrocortisone—Amcinonide—NR3C1—hematologic cancer	4.54e-05	0.0286	CrCbGaD
Fludrocortisone—Mometasone—NR3C1—hematologic cancer	4.32e-05	0.0272	CrCbGaD
Fludrocortisone—Spironolactone—AR—hematologic cancer	4.25e-05	0.0268	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—AR—hematologic cancer	3.98e-05	0.0251	CrCbGaD
Fludrocortisone—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.92e-05	0.0247	CrCbGaD
Fludrocortisone—Clobetasol propionate—NR3C1—hematologic cancer	3.81e-05	0.024	CrCbGaD
Fludrocortisone—Methyltestosterone—AR—hematologic cancer	3.75e-05	0.0236	CrCbGaD
Fludrocortisone—Fluorometholone—NR3C1—hematologic cancer	3.68e-05	0.0232	CrCbGaD
Fludrocortisone—Fluoxymesterone—ESR1—hematologic cancer	3.58e-05	0.0226	CrCbGaD
Fludrocortisone—Methylprednisolone—NR3C1—hematologic cancer	3.55e-05	0.0224	CrCbGaD
Fludrocortisone—Fluoxymesterone—NR3C1—hematologic cancer	3.15e-05	0.0199	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	3.07e-05	0.0194	CrCbGaD
Fludrocortisone—Triamcinolone—NR3C1—hematologic cancer	3e-05	0.0189	CrCbGaD
Fludrocortisone—Spironolactone—NR3C1—hematologic cancer	2.88e-05	0.0182	CrCbGaD
Fludrocortisone—Prednisone—NR3C1—hematologic cancer	2.72e-05	0.0171	CrCbGaD
Fludrocortisone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	2.7e-05	0.017	CrCbGaD
Fludrocortisone—Progesterone—SLC22A1—hematologic cancer	2.59e-05	0.0163	CrCbGaD
Fludrocortisone—Prednisolone—NR3C1—hematologic cancer	2.5e-05	0.0158	CrCbGaD
Fludrocortisone—Betamethasone—NR3C1—hematologic cancer	2.45e-05	0.0155	CrCbGaD
Fludrocortisone—Testosterone—SLC22A1—hematologic cancer	2.45e-05	0.0154	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.35e-05	0.000732	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK2—hematologic cancer	2.34e-05	0.00073	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.34e-05	0.000729	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—H3F3B—hematologic cancer	2.33e-05	0.000725	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—DNMT3B—hematologic cancer	2.33e-05	0.000725	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.32e-05	0.000722	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.31e-05	0.000719	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NR3C1—hematologic cancer	2.31e-05	0.000718	CbGpPWpGaD
Fludrocortisone—Progesterone—AR—hematologic cancer	2.3e-05	0.0145	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.3e-05	0.000717	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.28e-05	0.00071	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.27e-05	0.000707	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.25e-05	0.0007	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.25e-05	0.000699	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—EP300—hematologic cancer	2.24e-05	0.000698	CbGpPWpGaD
Fludrocortisone—Megestrol acetate—ABCB1—hematologic cancer	2.24e-05	0.0141	CrCbGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.23e-05	0.000694	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ATM—hematologic cancer	2.23e-05	0.000693	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCG2—hematologic cancer	2.22e-05	0.014	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CDK4—hematologic cancer	2.22e-05	0.00069	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—hematologic cancer	2.21e-05	0.000687	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—hematologic cancer	2.19e-05	0.000682	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CCND1—hematologic cancer	2.18e-05	0.00068	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—hematologic cancer	2.18e-05	0.000679	CbGpPWpGaD
Fludrocortisone—Testosterone—AR—hematologic cancer	2.18e-05	0.0137	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.17e-05	0.000675	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.16e-05	0.000674	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAD—hematologic cancer	2.15e-05	0.000671	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—FAS—hematologic cancer	2.15e-05	0.000671	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—RPS14—hematologic cancer	2.13e-05	0.000664	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CDKN1A—hematologic cancer	2.11e-05	0.000658	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—PTEN—hematologic cancer	2.11e-05	0.000657	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.1e-05	0.000656	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NUP98—hematologic cancer	2.1e-05	0.000653	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.09e-05	0.000651	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.09e-05	0.000651	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.09e-05	0.00065	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.08e-05	0.000647	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.06e-05	0.000642	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CASC3—hematologic cancer	2.06e-05	0.000641	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.04e-05	0.000636	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.03e-05	0.000633	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NUP214—hematologic cancer	2.02e-05	0.00063	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—EP300—hematologic cancer	2.01e-05	0.000626	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.01e-05	0.000625	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2e-05	0.000624	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	1.99e-05	0.000618	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	1.96e-05	0.000611	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—hematologic cancer	1.96e-05	0.00061	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—SRC—hematologic cancer	1.95e-05	0.000609	CbGpPWpGaD
Fludrocortisone—Oedema—Vincristine—hematologic cancer	1.95e-05	0.000243	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.94e-05	0.000605	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	1.94e-05	0.000605	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.94e-05	0.000604	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Melphalan—hematologic cancer	1.94e-05	0.000242	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisone—hematologic cancer	1.94e-05	0.000242	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.93e-05	0.000603	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Thalidomide—hematologic cancer	1.93e-05	0.000241	CcSEcCtD
Fludrocortisone—Infection—Vincristine—hematologic cancer	1.93e-05	0.000241	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Ifosfamide—hematologic cancer	1.93e-05	0.000241	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—RB1—hematologic cancer	1.93e-05	0.0006	CbGpPWpGaD
Fludrocortisone—Myalgia—Gemcitabine—hematologic cancer	1.93e-05	0.00024	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—hematologic cancer	1.92e-05	0.00024	CcSEcCtD
Fludrocortisone—Insomnia—Thalidomide—hematologic cancer	1.92e-05	0.00024	CcSEcCtD
Fludrocortisone—Hydrocortisone—NR3C1—hematologic cancer	1.92e-05	0.0121	CrCbGaD
Fludrocortisone—Diabetes mellitus—Doxorubicin—hematologic cancer	1.91e-05	0.000239	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—hematologic cancer	1.91e-05	0.000594	CbGpPWpGaD
Fludrocortisone—Erythema—Prednisolone—hematologic cancer	1.91e-05	0.000238	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Irinotecan—hematologic cancer	1.9e-05	0.000237	CcSEcCtD
Fludrocortisone—Oedema—Mitoxantrone—hematologic cancer	1.9e-05	0.000237	CcSEcCtD
Fludrocortisone—Oedema—Irinotecan—hematologic cancer	1.9e-05	0.000237	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mitoxantrone—hematologic cancer	1.9e-05	0.000237	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.89e-05	0.000589	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.89e-05	0.000588	CbGpPWpGaD
Fludrocortisone—Asthenia—Melphalan—hematologic cancer	1.89e-05	0.000236	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.89e-05	0.000588	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.89e-05	0.000587	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—hematologic cancer	1.89e-05	0.000587	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Lenalidomide—hematologic cancer	1.88e-05	0.000235	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.88e-05	0.000587	CbGpPWpGaD
Fludrocortisone—Infection—Irinotecan—hematologic cancer	1.88e-05	0.000235	CcSEcCtD
Fludrocortisone—Infection—Mitoxantrone—hematologic cancer	1.88e-05	0.000235	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Vincristine—hematologic cancer	1.88e-05	0.000235	CcSEcCtD
Fludrocortisone—Urticaria—Bortezomib—hematologic cancer	1.87e-05	0.000233	CcSEcCtD
Fludrocortisone—Purpura—Epirubicin—hematologic cancer	1.87e-05	0.000233	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.86e-05	0.000581	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EIF4EBP1—hematologic cancer	1.86e-05	0.00058	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—HSPB1—hematologic cancer	1.86e-05	0.00058	CbGpPWpGaD
Fludrocortisone—Vascular purpura—Doxorubicin—hematologic cancer	1.86e-05	0.000232	CcSEcCtD
Fludrocortisone—Hypersensitivity—Hydroxyurea—hematologic cancer	1.86e-05	0.000232	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—hematologic cancer	1.86e-05	0.000232	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Carmustine—hematologic cancer	1.86e-05	0.000232	CcSEcCtD
Fludrocortisone—Urticaria—Bleomycin—hematologic cancer	1.86e-05	0.000232	CcSEcCtD
Fludrocortisone—Headache—Nilotinib—hematologic cancer	1.85e-05	0.000231	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.85e-05	0.000576	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Gemcitabine—hematologic cancer	1.85e-05	0.000231	CcSEcCtD
Fludrocortisone—Oedema—Gemcitabine—hematologic cancer	1.85e-05	0.000231	CcSEcCtD
Fludrocortisone—Insomnia—Carmustine—hematologic cancer	1.84e-05	0.00023	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.84e-05	0.000574	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Alitretinoin—hematologic cancer	1.84e-05	0.00023	CcSEcCtD
Fludrocortisone—Headache—Imatinib—hematologic cancer	1.84e-05	0.00023	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.84e-05	0.000572	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Betamethasone—hematologic cancer	1.84e-05	0.000229	CcSEcCtD
Fludrocortisone—Haemoglobin—Dexamethasone—hematologic cancer	1.84e-05	0.000229	CcSEcCtD
Fludrocortisone—Asthenia—Lenalidomide—hematologic cancer	1.83e-05	0.000229	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—hematologic cancer	1.83e-05	0.000229	CcSEcCtD
Fludrocortisone—Infection—Gemcitabine—hematologic cancer	1.83e-05	0.000229	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Irinotecan—hematologic cancer	1.83e-05	0.000229	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mitoxantrone—hematologic cancer	1.83e-05	0.000229	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.83e-05	0.00057	CbGpPWpGaD
Fludrocortisone—Convulsion—Cisplatin—hematologic cancer	1.83e-05	0.000228	CcSEcCtD
Fludrocortisone—Insomnia—Alitretinoin—hematologic cancer	1.83e-05	0.000228	CcSEcCtD
Fludrocortisone—Haemorrhage—Dexamethasone—hematologic cancer	1.83e-05	0.000228	CcSEcCtD
Fludrocortisone—Haemorrhage—Betamethasone—hematologic cancer	1.83e-05	0.000228	CcSEcCtD
Fludrocortisone—Urticaria—Vinorelbine—hematologic cancer	1.83e-05	0.000228	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—hematologic cancer	1.82e-05	0.000227	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ifosfamide—hematologic cancer	1.82e-05	0.000227	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.81e-05	0.000565	CbGpPWpGaD
Fludrocortisone—Asthenia—Hydroxyurea—hematologic cancer	1.81e-05	0.000226	CcSEcCtD
Fludrocortisone—Headache—Cladribine—hematologic cancer	1.81e-05	0.000226	CcSEcCtD
Fludrocortisone—Myalgia—Cisplatin—hematologic cancer	1.79e-05	0.000224	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—hematologic cancer	1.79e-05	0.000224	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Gemcitabine—hematologic cancer	1.78e-05	0.000223	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.78e-05	0.000556	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.78e-05	0.000556	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.78e-05	0.000555	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SMC1A—hematologic cancer	1.78e-05	0.000555	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Vincristine—hematologic cancer	1.77e-05	0.000221	CcSEcCtD
Fludrocortisone—Progesterone—ESR1—hematologic cancer	1.77e-05	0.0112	CrCbGaD
Fludrocortisone—Affect lability—Epirubicin—hematologic cancer	1.77e-05	0.000221	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.77e-05	0.00055	CbGpPWpGaD
Fludrocortisone—Insomnia—Vincristine—hematologic cancer	1.76e-05	0.00022	CcSEcCtD
Fludrocortisone—Erythema—Triamcinolone—hematologic cancer	1.75e-05	0.000219	CcSEcCtD
Fludrocortisone—AR—Gene Expression—RARS—hematologic cancer	1.75e-05	0.000545	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—H3F3A—hematologic cancer	1.75e-05	0.000544	CbGpPWpGaD
Fludrocortisone—Urticaria—Thiotepa—hematologic cancer	1.74e-05	0.000218	CcSEcCtD
Fludrocortisone—Vertigo—Etoposide—hematologic cancer	1.74e-05	0.000217	CcSEcCtD
Fludrocortisone—Hypersensitivity—Bortezomib—hematologic cancer	1.73e-05	0.000217	CcSEcCtD
Fludrocortisone—Headache—Vinblastine—hematologic cancer	1.73e-05	0.000216	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.73e-05	0.000538	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	1.73e-05	0.000216	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—hematologic cancer	1.73e-05	0.000216	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—hematologic cancer	1.72e-05	0.000215	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Cisplatin—hematologic cancer	1.72e-05	0.000215	CcSEcCtD
Fludrocortisone—Hypersensitivity—Bleomycin—hematologic cancer	1.72e-05	0.000215	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—hematologic cancer	1.72e-05	0.000215	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CREBBP—hematologic cancer	1.72e-05	0.000534	CbGpPWpGaD
Fludrocortisone—Methylprednisolone—ABCB1—hematologic cancer	1.71e-05	0.0108	CrCbGaD
Fludrocortisone—Insomnia—Irinotecan—hematologic cancer	1.71e-05	0.000214	CcSEcCtD
Fludrocortisone—Vertigo—Prednisolone—hematologic cancer	1.71e-05	0.000214	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.71e-05	0.000533	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCG2—hematologic cancer	1.71e-05	0.0108	CrCbGaD
Fludrocortisone—Infection—Cisplatin—hematologic cancer	1.71e-05	0.000213	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—hematologic cancer	1.7e-05	0.000213	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.7e-05	0.000529	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Vinorelbine—hematologic cancer	1.69e-05	0.000211	CcSEcCtD
Fludrocortisone—Asthenia—Bortezomib—hematologic cancer	1.69e-05	0.000211	CcSEcCtD
Fludrocortisone—Urticaria—Thalidomide—hematologic cancer	1.69e-05	0.000211	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	1.68e-05	0.00021	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—EZH2—hematologic cancer	1.68e-05	0.000522	CbGpPWpGaD
Fludrocortisone—Asthenia—Bleomycin—hematologic cancer	1.68e-05	0.000209	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—hematologic cancer	1.67e-05	0.000209	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.67e-05	0.00052	CbGpPWpGaD
Fludrocortisone—Insomnia—Gemcitabine—hematologic cancer	1.67e-05	0.000209	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—hematologic cancer	1.67e-05	0.000208	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	1.67e-05	0.000519	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Cisplatin—hematologic cancer	1.66e-05	0.000208	CcSEcCtD
Fludrocortisone—Dexamethasone—ABCG2—hematologic cancer	1.66e-05	0.0104	CrCbGaD
Fludrocortisone—Convulsion—Prednisolone—hematologic cancer	1.65e-05	0.000206	CcSEcCtD
Fludrocortisone—Asthenia—Vinorelbine—hematologic cancer	1.65e-05	0.000206	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—RB1—hematologic cancer	1.65e-05	0.000513	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.65e-05	0.000512	CbGpPWpGaD
Fludrocortisone—Hypertension—Prednisolone—hematologic cancer	1.64e-05	0.000205	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.64e-05	0.000512	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—POLR3E—hematologic cancer	1.64e-05	0.000512	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.64e-05	0.000512	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—hematologic cancer	1.64e-05	0.000512	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	1.64e-05	0.000512	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PARP1—hematologic cancer	1.64e-05	0.000511	CbGpPWpGaD
Fludrocortisone—Affect lability—Doxorubicin—hematologic cancer	1.64e-05	0.000204	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.63e-05	0.000507	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Methotrexate—hematologic cancer	1.63e-05	0.000203	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.62e-05	0.000504	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Thiotepa—hematologic cancer	1.62e-05	0.000202	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.61e-05	0.000502	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.61e-05	0.000501	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.61e-05	0.0005	CbGpPWpGaD
Fludrocortisone—Urticaria—Alitretinoin—hematologic cancer	1.6e-05	0.0002	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.6e-05	0.000499	CbGpPWpGaD
Fludrocortisone—Headache—Lenalidomide—hematologic cancer	1.6e-05	0.0002	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisone—hematologic cancer	1.6e-05	0.0002	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	1.6e-05	0.000498	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Prednisone—hematologic cancer	1.59e-05	0.000199	CcSEcCtD
Fludrocortisone—Erythema—Betamethasone—hematologic cancer	1.59e-05	0.000199	CcSEcCtD
Fludrocortisone—Erythema—Dexamethasone—hematologic cancer	1.59e-05	0.000199	CcSEcCtD
Fludrocortisone—Muscular weakness—Epirubicin—hematologic cancer	1.59e-05	0.000198	CcSEcCtD
Fludrocortisone—Urticaria—Ifosfamide—hematologic cancer	1.59e-05	0.000198	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—HDAC2—hematologic cancer	1.58e-05	0.000493	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PARP1—hematologic cancer	1.58e-05	0.000493	CbGpPWpGaD
Fludrocortisone—Headache—Hydroxyurea—hematologic cancer	1.58e-05	0.000197	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Etoposide—hematologic cancer	1.58e-05	0.000197	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—hematologic cancer	1.58e-05	0.000197	CcSEcCtD
Fludrocortisone—Asthenia—Thiotepa—hematologic cancer	1.57e-05	0.000197	CcSEcCtD
Fludrocortisone—Vertigo—Triamcinolone—hematologic cancer	1.57e-05	0.000197	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—hematologic cancer	1.57e-05	0.000196	CcSEcCtD
Fludrocortisone—Infection—Etoposide—hematologic cancer	1.57e-05	0.000196	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—hematologic cancer	1.56e-05	0.000195	CcSEcCtD
Fludrocortisone—Hypersensitivity—Thalidomide—hematologic cancer	1.56e-05	0.000195	CcSEcCtD
Fludrocortisone—Progesterone—NR3C1—hematologic cancer	1.56e-05	0.00984	CrCbGaD
Fludrocortisone—Oedema—Prednisolone—hematologic cancer	1.55e-05	0.000194	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisolone—hematologic cancer	1.55e-05	0.000194	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.53e-05	0.000476	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Etoposide—hematologic cancer	1.52e-05	0.00019	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—hematologic cancer	1.52e-05	0.00019	CcSEcCtD
Fludrocortisone—Asthenia—Thalidomide—hematologic cancer	1.52e-05	0.00019	CcSEcCtD
Fludrocortisone—Convulsion—Triamcinolone—hematologic cancer	1.52e-05	0.00019	CcSEcCtD
Fludrocortisone—Hypertension—Triamcinolone—hematologic cancer	1.51e-05	0.000189	CcSEcCtD
Fludrocortisone—Urticaria—Mitoxantrone—hematologic cancer	1.51e-05	0.000188	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Prednisolone—hematologic cancer	1.5e-05	0.000188	CcSEcCtD
Fludrocortisone—Hypersensitivity—Carmustine—hematologic cancer	1.5e-05	0.000188	CcSEcCtD
Fludrocortisone—Myalgia—Triamcinolone—hematologic cancer	1.49e-05	0.000186	CcSEcCtD
Fludrocortisone—Hypersensitivity—Alitretinoin—hematologic cancer	1.49e-05	0.000186	CcSEcCtD
Fludrocortisone—Headache—Bortezomib—hematologic cancer	1.47e-05	0.000184	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ifosfamide—hematologic cancer	1.47e-05	0.000184	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	1.47e-05	0.000458	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.47e-05	0.000457	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Doxorubicin—hematologic cancer	1.47e-05	0.000183	CcSEcCtD
Fludrocortisone—Asthenia—Carmustine—hematologic cancer	1.46e-05	0.000183	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.46e-05	0.000455	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.45e-05	0.000453	CbGpPWpGaD
Fludrocortisone—Asthenia—Alitretinoin—hematologic cancer	1.45e-05	0.000181	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—hematologic cancer	1.45e-05	0.000181	CcSEcCtD
Fludrocortisone—Headache—Vinorelbine—hematologic cancer	1.44e-05	0.00018	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.44e-05	0.000447	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Vincristine—hematologic cancer	1.43e-05	0.000179	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.43e-05	0.000446	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.43e-05	0.000446	CbGpPWpGaD
Fludrocortisone—Asthenia—Ifosfamide—hematologic cancer	1.43e-05	0.000179	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.43e-05	0.000446	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	1.43e-05	0.000446	CbGpPWpGaD
Fludrocortisone—Oedema—Triamcinolone—hematologic cancer	1.43e-05	0.000179	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Triamcinolone—hematologic cancer	1.43e-05	0.000179	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.43e-05	0.000445	CbGpPWpGaD
Fludrocortisone—Vertigo—Dexamethasone—hematologic cancer	1.43e-05	0.000178	CcSEcCtD
Fludrocortisone—Vertigo—Betamethasone—hematologic cancer	1.43e-05	0.000178	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—hematologic cancer	1.43e-05	0.000445	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NR3C1—hematologic cancer	1.43e-05	0.009	CrCbGaD
Fludrocortisone—AR—Gene Expression—TET2—hematologic cancer	1.43e-05	0.000444	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RARA—hematologic cancer	1.43e-05	0.000444	CbGpPWpGaD
Fludrocortisone—Infection—Triamcinolone—hematologic cancer	1.42e-05	0.000177	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—hematologic cancer	1.41e-05	0.000176	CcSEcCtD
Fludrocortisone—Insomnia—Prednisolone—hematologic cancer	1.41e-05	0.000176	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—hematologic cancer	1.4e-05	0.000175	CcSEcCtD
Fludrocortisone—AR—Gene Expression—RPLP1—hematologic cancer	1.4e-05	0.000436	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Irinotecan—hematologic cancer	1.4e-05	0.000174	CcSEcCtD
Fludrocortisone—Hypersensitivity—Mitoxantrone—hematologic cancer	1.4e-05	0.000174	CcSEcCtD
Fludrocortisone—Asthenia—Vincristine—hematologic cancer	1.4e-05	0.000174	CcSEcCtD
Fludrocortisone—Spironolactone—ABCB1—hematologic cancer	1.39e-05	0.00877	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.39e-05	0.000433	CbGpPWpGaD
Fludrocortisone—Erythema—Prednisone—hematologic cancer	1.38e-05	0.000173	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Triamcinolone—hematologic cancer	1.38e-05	0.000173	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.38e-05	0.00043	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	1.38e-05	0.00043	CbGpPWpGaD
Fludrocortisone—Convulsion—Betamethasone—hematologic cancer	1.38e-05	0.000172	CcSEcCtD
Fludrocortisone—Convulsion—Dexamethasone—hematologic cancer	1.38e-05	0.000172	CcSEcCtD
Fludrocortisone—Headache—Thiotepa—hematologic cancer	1.37e-05	0.000172	CcSEcCtD
Fludrocortisone—Prednisone—ALB—hematologic cancer	1.37e-05	0.00866	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—AR—hematologic cancer	1.37e-05	0.000428	CbGpPWpGaD
Fludrocortisone—Hypertension—Dexamethasone—hematologic cancer	1.37e-05	0.000171	CcSEcCtD
Fludrocortisone—Hypertension—Betamethasone—hematologic cancer	1.37e-05	0.000171	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.36e-05	0.000424	CbGpPWpGaD
Fludrocortisone—Asthenia—Irinotecan—hematologic cancer	1.36e-05	0.00017	CcSEcCtD
Fludrocortisone—Asthenia—Mitoxantrone—hematologic cancer	1.36e-05	0.00017	CcSEcCtD
Fludrocortisone—Myalgia—Betamethasone—hematologic cancer	1.35e-05	0.000169	CcSEcCtD
Fludrocortisone—Myalgia—Dexamethasone—hematologic cancer	1.35e-05	0.000169	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—hematologic cancer	1.34e-05	0.000167	CcSEcCtD
Fludrocortisone—Headache—Thalidomide—hematologic cancer	1.33e-05	0.000166	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—hematologic cancer	1.33e-05	0.000166	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—RARS—hematologic cancer	1.33e-05	0.000413	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NR0B2—hematologic cancer	1.33e-05	0.000413	CbGpPWpGaD
Fludrocortisone—Asthenia—Gemcitabine—hematologic cancer	1.32e-05	0.000165	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.32e-05	0.000412	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—EP300—hematologic cancer	1.32e-05	0.00041	CbGpPWpGaD
Fludrocortisone—Prednisone—ABCB1—hematologic cancer	1.31e-05	0.00827	CrCbGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.31e-05	0.000408	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	1.3e-05	0.000163	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Betamethasone—hematologic cancer	1.3e-05	0.000162	CcSEcCtD
Fludrocortisone—Oedema—Betamethasone—hematologic cancer	1.3e-05	0.000162	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Dexamethasone—hematologic cancer	1.3e-05	0.000162	CcSEcCtD
Fludrocortisone—Oedema—Dexamethasone—hematologic cancer	1.3e-05	0.000162	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Doxorubicin—hematologic cancer	1.3e-05	0.000162	CcSEcCtD
Fludrocortisone—Insomnia—Triamcinolone—hematologic cancer	1.29e-05	0.000161	CcSEcCtD
Fludrocortisone—Infection—Betamethasone—hematologic cancer	1.29e-05	0.000161	CcSEcCtD
Fludrocortisone—Infection—Dexamethasone—hematologic cancer	1.29e-05	0.000161	CcSEcCtD
Fludrocortisone—Methyltestosterone—ALB—hematologic cancer	1.29e-05	0.00811	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.28e-05	0.0004	CbGpPWpGaD
Fludrocortisone—Headache—Carmustine—hematologic cancer	1.28e-05	0.000159	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cisplatin—hematologic cancer	1.27e-05	0.000158	CcSEcCtD
Fludrocortisone—Headache—Alitretinoin—hematologic cancer	1.27e-05	0.000158	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—CDKN2B—hematologic cancer	1.26e-05	0.000394	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT3A—hematologic cancer	1.26e-05	0.000394	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Betamethasone—hematologic cancer	1.25e-05	0.000157	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Dexamethasone—hematologic cancer	1.25e-05	0.000157	CcSEcCtD
Fludrocortisone—Urticaria—Etoposide—hematologic cancer	1.25e-05	0.000156	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—hematologic cancer	1.25e-05	0.000156	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.25e-05	0.000389	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	1.25e-05	0.000389	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ELL—hematologic cancer	1.25e-05	0.000388	CbGpPWpGaD
Fludrocortisone—Vertigo—Prednisone—hematologic cancer	1.24e-05	0.000155	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—hematologic cancer	1.24e-05	0.000155	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.24e-05	0.000387	CbGpPWpGaD
Fludrocortisone—Urticaria—Prednisolone—hematologic cancer	1.24e-05	0.000154	CcSEcCtD
Fludrocortisone—Asthenia—Cisplatin—hematologic cancer	1.23e-05	0.000154	CcSEcCtD
Fludrocortisone—Headache—Vincristine—hematologic cancer	1.22e-05	0.000152	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.22e-05	0.00038	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.22e-05	0.000379	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.22e-05	0.000379	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—hematologic cancer	1.21e-05	0.000378	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.21e-05	0.000377	CbGpPWpGaD
Fludrocortisone—Prednisolone—ABCB1—hematologic cancer	1.21e-05	0.00762	CrCbGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.2e-05	0.000374	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NCOR1—hematologic cancer	1.2e-05	0.000374	CbGpPWpGaD
Fludrocortisone—Convulsion—Prednisone—hematologic cancer	1.2e-05	0.00015	CcSEcCtD
Fludrocortisone—AR—Gene Expression—NCOR2—hematologic cancer	1.2e-05	0.000373	CbGpPWpGaD
Fludrocortisone—Hypertension—Prednisone—hematologic cancer	1.2e-05	0.000149	CcSEcCtD
Fludrocortisone—Headache—Mitoxantrone—hematologic cancer	1.19e-05	0.000148	CcSEcCtD
Fludrocortisone—Headache—Irinotecan—hematologic cancer	1.19e-05	0.000148	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.19e-05	0.000369	CbGpPWpGaD
Fludrocortisone—Betamethasone—ABCB1—hematologic cancer	1.18e-05	0.00747	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.18e-05	0.000369	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.18e-05	0.000369	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.18e-05	0.000148	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.18e-05	0.000148	CcSEcCtD
Fludrocortisone—Myalgia—Prednisone—hematologic cancer	1.18e-05	0.000147	CcSEcCtD
Fludrocortisone—Insomnia—Betamethasone—hematologic cancer	1.17e-05	0.000147	CcSEcCtD
Fludrocortisone—Insomnia—Dexamethasone—hematologic cancer	1.17e-05	0.000147	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.17e-05	0.000363	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Etoposide—hematologic cancer	1.16e-05	0.000145	CcSEcCtD
Fludrocortisone—Erythema—Methotrexate—hematologic cancer	1.16e-05	0.000144	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—hematologic cancer	1.16e-05	0.000144	CcSEcCtD
Fludrocortisone—Headache—Gemcitabine—hematologic cancer	1.16e-05	0.000144	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—NCOR1—hematologic cancer	1.16e-05	0.00036	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Doxorubicin—hematologic cancer	1.15e-05	0.000144	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—MYC—hematologic cancer	1.15e-05	0.000358	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.15e-05	0.000357	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Prednisolone—hematologic cancer	1.15e-05	0.000143	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.14e-05	0.000356	CbGpPWpGaD
Fludrocortisone—Urticaria—Triamcinolone—hematologic cancer	1.14e-05	0.000142	CcSEcCtD
Fludrocortisone—Asthenia—Etoposide—hematologic cancer	1.13e-05	0.000141	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisone—hematologic cancer	1.13e-05	0.000141	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—hematologic cancer	1.13e-05	0.000141	CcSEcCtD
Fludrocortisone—Infection—Prednisone—hematologic cancer	1.12e-05	0.00014	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.12e-05	0.000349	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NR3C1—hematologic cancer	1.11e-05	0.000346	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AGO2—hematologic cancer	1.1e-05	0.000344	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Prednisone—hematologic cancer	1.09e-05	0.000136	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.09e-05	0.00034	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.09e-05	0.000339	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.09e-05	0.000338	CbGpPWpGaD
Fludrocortisone—Erythema—Epirubicin—hematologic cancer	1.08e-05	0.000135	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—RARA—hematologic cancer	1.08e-05	0.000337	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TET2—hematologic cancer	1.08e-05	0.000337	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—DNMT3B—hematologic cancer	1.08e-05	0.000337	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—H3F3B—hematologic cancer	1.08e-05	0.000337	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NR3C1—hematologic cancer	1.07e-05	0.000333	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.07e-05	0.000332	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.06e-05	0.000331	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.06e-05	0.00033	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	1.06e-05	0.00033	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.06e-05	0.000329	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.06e-05	0.000329	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Triamcinolone—hematologic cancer	1.05e-05	0.000132	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.04e-05	0.000324	CbGpPWpGaD
Fludrocortisone—Vertigo—Methotrexate—hematologic cancer	1.04e-05	0.00013	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.03e-05	0.000322	CbGpPWpGaD
Fludrocortisone—Urticaria—Betamethasone—hematologic cancer	1.03e-05	0.000129	CcSEcCtD
Fludrocortisone—Urticaria—Dexamethasone—hematologic cancer	1.03e-05	0.000129	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.03e-05	0.000129	CcSEcCtD
Fludrocortisone—Asthenia—Triamcinolone—hematologic cancer	1.03e-05	0.000128	CcSEcCtD
Fludrocortisone—Insomnia—Prednisone—hematologic cancer	1.02e-05	0.000128	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—MYC—hematologic cancer	1.02e-05	0.000317	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.01e-05	0.000313	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1e-05	0.000313	CbGpPWpGaD
Fludrocortisone—Convulsion—Methotrexate—hematologic cancer	1e-05	0.000125	CcSEcCtD
Fludrocortisone—Erythema—Doxorubicin—hematologic cancer	1e-05	0.000125	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	9.94e-06	0.00031	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—RPS14—hematologic cancer	9.88e-06	0.000308	CbGpPWpGaD
Fludrocortisone—Headache—Etoposide—hematologic cancer	9.88e-06	0.000123	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—hematologic cancer	9.85e-06	0.000123	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	9.84e-06	0.000307	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—hematologic cancer	9.79e-06	0.000305	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.78e-06	0.000305	CbGpPWpGaD
Fludrocortisone—Headache—Prednisolone—hematologic cancer	9.74e-06	0.000122	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	9.73e-06	0.000303	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NUP98—hematologic cancer	9.73e-06	0.000303	CbGpPWpGaD
Fludrocortisone—Vertigo—Epirubicin—hematologic cancer	9.73e-06	0.000121	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—MAPK14—hematologic cancer	9.61e-06	0.000299	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT3A—hematologic cancer	9.59e-06	0.000299	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.51e-06	0.000296	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.49e-06	0.000296	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ELL—hematologic cancer	9.45e-06	0.000295	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Methotrexate—hematologic cancer	9.44e-06	0.000118	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—hematologic cancer	9.42e-06	0.000294	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—hematologic cancer	9.42e-06	0.000294	CbGpPWpGaD
Fludrocortisone—Convulsion—Epirubicin—hematologic cancer	9.38e-06	0.000117	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—hematologic cancer	9.38e-06	0.000117	CcSEcCtD
Fludrocortisone—AR—Gene Expression—NUP214—hematologic cancer	9.38e-06	0.000292	CbGpPWpGaD
Fludrocortisone—Hypertension—Epirubicin—hematologic cancer	9.35e-06	0.000117	CcSEcCtD
Fludrocortisone—Asthenia—Betamethasone—hematologic cancer	9.31e-06	0.000116	CcSEcCtD
Fludrocortisone—Asthenia—Dexamethasone—hematologic cancer	9.31e-06	0.000116	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	9.25e-06	0.000288	CbGpPWpGaD
Fludrocortisone—Hydrocortisone—ABCB1—hematologic cancer	9.24e-06	0.00583	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	9.22e-06	0.000287	CbGpPWpGaD
Fludrocortisone—Myalgia—Epirubicin—hematologic cancer	9.22e-06	0.000115	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—TNF—hematologic cancer	9.14e-06	0.000285	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Methotrexate—hematologic cancer	9.13e-06	0.000114	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—hematologic cancer	9.11e-06	0.000284	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—hematologic cancer	9.08e-06	0.000283	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOR2—hematologic cancer	9.08e-06	0.000283	CbGpPWpGaD
Fludrocortisone—Vertigo—Doxorubicin—hematologic cancer	9e-06	0.000112	CcSEcCtD
Fludrocortisone—Urticaria—Prednisone—hematologic cancer	8.98e-06	0.000112	CcSEcCtD
Fludrocortisone—Headache—Triamcinolone—hematologic cancer	8.96e-06	0.000112	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.86e-06	0.000276	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Epirubicin—hematologic cancer	8.84e-06	0.00011	CcSEcCtD
Fludrocortisone—Oedema—Epirubicin—hematologic cancer	8.84e-06	0.00011	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.79e-06	0.000274	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	8.78e-06	0.000273	CbGpPWpGaD
Fludrocortisone—Infection—Epirubicin—hematologic cancer	8.78e-06	0.00011	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	8.77e-06	0.000273	CbGpPWpGaD
Fludrocortisone—Convulsion—Doxorubicin—hematologic cancer	8.68e-06	0.000108	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—hematologic cancer	8.65e-06	0.000108	CcSEcCtD
Fludrocortisone—AR—Gene Expression—EIF4EBP1—hematologic cancer	8.64e-06	0.000269	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HSPB1—hematologic cancer	8.64e-06	0.000269	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.6e-06	0.000107	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—hematologic cancer	8.54e-06	0.000107	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—hematologic cancer	8.54e-06	0.000107	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—hematologic cancer	8.53e-06	0.000107	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	8.4e-06	0.000262	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AGO2—hematologic cancer	8.37e-06	0.000261	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Prednisone—hematologic cancer	8.32e-06	0.000104	CcSEcCtD
Fludrocortisone—AR—Gene Expression—SMC1A—hematologic cancer	8.27e-06	0.000258	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—CREBBP—hematologic cancer	8.26e-06	0.000257	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—DNMT3B—hematologic cancer	8.2e-06	0.000255	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—H3F3B—hematologic cancer	8.2e-06	0.000255	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Doxorubicin—hematologic cancer	8.18e-06	0.000102	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—hematologic cancer	8.18e-06	0.000102	CcSEcCtD
Fludrocortisone—Headache—Betamethasone—hematologic cancer	8.13e-06	0.000101	CcSEcCtD
Fludrocortisone—Headache—Dexamethasone—hematologic cancer	8.13e-06	0.000101	CcSEcCtD
Fludrocortisone—Infection—Doxorubicin—hematologic cancer	8.12e-06	0.000101	CcSEcCtD
Fludrocortisone—AR—Gene Expression—H3F3A—hematologic cancer	8.11e-06	0.000253	CbGpPWpGaD
Fludrocortisone—Asthenia—Prednisone—hematologic cancer	8.11e-06	0.000101	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.07e-06	0.000251	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.05e-06	0.000101	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—hematologic cancer	7.99e-06	9.98e-05	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	7.96e-06	0.000248	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	7.96e-06	0.000248	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Doxorubicin—hematologic cancer	7.9e-06	9.87e-05	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	7.9e-06	0.000246	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.81e-06	0.000243	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EZH2—hematologic cancer	7.78e-06	0.000242	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PARP1—hematologic cancer	7.61e-06	0.000237	CbGpPWpGaD
Fludrocortisone—Progesterone—ABCB1—hematologic cancer	7.53e-06	0.00475	CrCbGaD
Fludrocortisone—Urticaria—Methotrexate—hematologic cancer	7.5e-06	9.37e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—RPS14—hematologic cancer	7.5e-06	0.000234	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—hematologic cancer	7.46e-06	0.0047	CrCbGaD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.45e-06	9.3e-05	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—hematologic cancer	7.39e-06	9.23e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—NUP98—hematologic cancer	7.38e-06	0.00023	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—hematologic cancer	7.38e-06	0.00023	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—HDAC2—hematologic cancer	7.34e-06	0.000229	CbGpPWpGaD
Fludrocortisone—Testosterone—ABCB1—hematologic cancer	7.12e-06	0.00449	CrCbGaD
Fludrocortisone—NR3C1—Gene Expression—NUP214—hematologic cancer	7.11e-06	0.000222	CbGpPWpGaD
Fludrocortisone—Headache—Prednisone—hematologic cancer	7.08e-06	8.84e-05	CcSEcCtD
Fludrocortisone—Urticaria—Epirubicin—hematologic cancer	7.02e-06	8.77e-05	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methotrexate—hematologic cancer	6.96e-06	8.69e-05	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	6.89e-06	0.000215	CbGpPWpGaD
Fludrocortisone—Dexamethasone—ABCB1—hematologic cancer	6.89e-06	0.00434	CrCbGaD
Fludrocortisone—Asthenia—Methotrexate—hematologic cancer	6.77e-06	8.46e-05	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	6.66e-06	0.000207	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.59e-06	0.000205	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HSPB1—hematologic cancer	6.55e-06	0.000204	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	6.55e-06	0.000204	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Epirubicin—hematologic cancer	6.51e-06	8.13e-05	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—hematologic cancer	6.5e-06	8.11e-05	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	6.38e-06	0.000199	CbGpPWpGaD
Fludrocortisone—Asthenia—Epirubicin—hematologic cancer	6.34e-06	7.92e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—SMC1A—hematologic cancer	6.28e-06	0.000196	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—H3F3A—hematologic cancer	6.15e-06	0.000192	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	6.04e-06	0.000188	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Doxorubicin—hematologic cancer	6.02e-06	7.52e-05	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—hematologic cancer	5.92e-06	7.39e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—EZH2—hematologic cancer	5.9e-06	0.000184	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CDKN2B—hematologic cancer	5.87e-06	0.000183	CbGpPWpGaD
Fludrocortisone—Asthenia—Doxorubicin—hematologic cancer	5.87e-06	7.33e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—PARP1—hematologic cancer	5.78e-06	0.00018	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—HDAC2—hematologic cancer	5.57e-06	0.000174	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NCOR1—hematologic cancer	5.57e-06	0.000173	CbGpPWpGaD
Fludrocortisone—Headache—Epirubicin—hematologic cancer	5.54e-06	6.91e-05	CcSEcCtD
Fludrocortisone—AR—Gene Expression—NR3C1—hematologic cancer	5.15e-06	0.00016	CbGpPWpGaD
Fludrocortisone—Headache—Doxorubicin—hematologic cancer	5.12e-06	6.4e-05	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—MAPK3—hematologic cancer	5.04e-06	0.000157	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—MYC—hematologic cancer	4.9e-06	0.000153	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AR—hematologic cancer	4.83e-06	0.000151	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—MYC—hematologic cancer	4.72e-06	0.000147	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK14—hematologic cancer	4.46e-06	0.000139	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	4.45e-06	0.000139	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—hematologic cancer	4.37e-06	0.000136	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—hematologic cancer	4.23e-06	0.000132	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NCOR1—hematologic cancer	4.22e-06	0.000132	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CREBBP—hematologic cancer	3.83e-06	0.000119	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.58e-06	0.000112	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—hematologic cancer	3.4e-06	0.000106	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK14—hematologic cancer	3.38e-06	0.000105	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—hematologic cancer	3.32e-06	0.000103	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	3.21e-06	9.99e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.91e-06	9.06e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MAPK3—hematologic cancer	2.34e-06	7.28e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—MYC—hematologic cancer	2.27e-06	7.09e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.77e-06	5.53e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—MYC—hematologic cancer	1.73e-06	5.38e-05	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—hematologic cancer	1.58e-06	4.91e-05	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.2e-06	3.73e-05	CbGpPWpGaD
